The ability of CDDO-Me to decrease NOX2 expression, probably due to the suppression of TNFα [65], and increase SOD2 and catalase gene expression in our study further supports the hypothesis that its ability to normalize redox enzyme expression is responsible for the observed attenuation of endothelial dysfunction. The gene discussed is SOD2; the disease is endothelial dysfunction.